Rituxan Hycela 2000 U/mL
rituximab and hyaluronidase · INJECTION, SOLUTION · Genentech, Inc.
Rituxan Hycela is a injection, solution containing rituximab and hyaluronidase at 2000 U/mL, taken subcutaneous. Manufactured by Genentech, Inc..
Key Facts
- Brand Name
- Rituxan Hycela
- Generic Name
- rituximab and hyaluronidase
- NDC Code (Product)
50242-108- Manufacturer
- Genentech, Inc.
- Strength
- 2000 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761064
- Drug Class
- Endoglycosidase [EPC]; CD20-directed Cytolytic Antibody [EPC]
- Marketing Start
- 06/22/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Rituxan Hycela used for?
Rituxan Hycela contains rituximab and hyaluronidase. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Rituxan Hycela a controlled substance?
Rituxan Hycela is not classified as a controlled substance by the DEA.
What is the generic name for Rituxan Hycela?
The generic name for Rituxan Hycela is rituximab and hyaluronidase. There are no other listed brand versions of rituximab and hyaluronidase.
What is the NDC code for Rituxan Hycela 2000 U/mL?
The NDC (National Drug Code) for Rituxan Hycela 2000 U/mL is 50242-108, listed by Genentech, Inc..
Other Rituxan Hycela Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)